| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome c oxidase subunit 7A2 like | 0.736 | 0.385 | 1.2E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
LEM domain containing 3 | 0.582 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
beta-1,3-glucuronyltransferase 2 | 0.931 | 0.115 | 3.3E-05 |
|
phenotype | 0.110 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
UBA6 antisense RNA 1 (head to head) | 0.861 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||||||
|
WW domain containing oxidoreductase | 0.453 | 0.808 | 1.2E-15 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
IQ motif containing GTPase activating protein 2 | 0.674 | 0.269 | 8.5E-27 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
protein kinase C eta | 0.653 | 0.577 | 0.43 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
inositol 1,4,5-trisphosphate receptor type 3 | 0.555 | 0.808 | 2.6E-22 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
nucleoporin 205 | 0.736 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
transmembrane serine protease 11D | 0.636 | 0.538 | 1.2E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
reelin | 0.515 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
lymphocyte antigen 86 | 0.805 | 0.231 | 2.3E-05 |
|
phenotype | 0.120 | None | 1.000 | 1 | 1 | 2011 | 2017 | ||||||||
|
family with sequence similarity 98 member A | 0.805 | 0.231 | 0.55 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
transient receptor potential cation channel subfamily M member 3 | 0.663 | 0.769 | 5.7E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.200 | None | 0.958 | 9 | 9 | 2005 | 2019 | |||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
phenotype | 0.500 | None | 0.937 | 5 | 2 | 1997 | 2019 | ||||||||
|
ZFPM2 antisense RNA 1 | 0.736 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2015 | 2019 | |||||||||
|
zinc finger protein, FOG family member 2 | 0.565 | 0.731 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 4 | 3 | 2015 | 2019 | ||||||||
|
protein C receptor | 0.560 | 0.692 | 5.6E-03 |
|
phenotype | 0.200 | None | 0.875 | 4 | 5 | 2001 | 2019 | ||||||||
|
OSMR antisense RNA 1 (head to head) | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2019 | 2019 | |||||||||
|
coagulation factor IX | 0.465 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
F11 antisense RNA 1 | 0.805 | 0.308 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2011 | 2019 | |||||||||
|
G protein-coupled receptor kinase 5 | 0.588 | 0.769 | 0.68 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 | ||||||||
|
FUN14 domain containing 2 | 0.760 | 0.385 | 6.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | ||||||||
|
complement component 4 binding protein alpha | 0.556 | 0.846 | 0.46 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2019 | 2019 |